Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, medicaid and other US Government payers perspectives: The ISPOR drug cost task force report - Part IV

C. Daniel Mullins, Brian Seal, Enrique Seoane-Vazquez, Jayashri Sankaranarayanan, Carl V. Asche, Ravishankar Jayadevappa, Won Chan Lee, Dorothy K. Romanus, Junling Wang, Joel W. Hay, Jim Smeeding

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Good research practices for measuring drug costs in cost-effectiveness analyses: Medicare, medicaid and other US Government payers perspectives: The ISPOR drug cost task force report - Part IV'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences